Early buyers will receive 10% customization on this report.
This report studies the global life science instrumentation market over the forecast period of 2016 to 2021. The market is expected to reach USD 64.52 Billion by 2021, at CAGR of 6.8% from 2016 to 2021.
A number of factors such as increasing spending on pharmaceutical R&D, growing food safety concerns, availability of public and private funding for life science research, and continuous technological advancements in analytical instruments are fueling the growth of the life science instrumentation market. On the other hand, presence of alternative analytical technologies, high cost of instruments, and need for skilled professionals are some of the key factors limiting the growth of the global life science instrumentation market.
Based on the type of technology, the global life science instrumentation market is divided into thirteen segments, namely, cell counting, centrifuges, chromatography, electrophoresis, flow cytometry, immunoassays, liquid handling and robotics, microscopy, next-generation sequencing, PCR, spectroscopy, western blotting, and other technologies. The other technologies segment includes heat sterilization, colorimeter, fume hoods, incubators, laboratory balances, microplate systems, and laboratory freezers.
On the basis of end users, the global life science instrumentation market is segmented into pharmaceutical and biotechnology companies; CROs; research institutions; hospitals, clinics, and diagnostic laboratories; academic institutions; forensic science laboratories; food and agriculture industry; environmental testing industry; and other end users.
On the basis of applications, the life science instrumentation market is segmented into research applications; clinical and diagnostic applications; and other applications. The other applications segment comprises food and beverage testing, environmental testing, industrial chemistry, forensics, cosmetic industry, and petrochemical industry.
As of 2016, North America held the largest share of the global life science instrumentation market, followed by Europe. However, the Asia-Pacific market is expected to register the highest CAGR of 8.6% from 2016 to 2021. Factors such as strategic expansions by key market players in emerging Asian countries; growing pharmaceutical industry in India and China; and increasing government investment in biomedical industry in China and Singapore are stimulating the growth of the life science instrumentation market in the Asia-Pacific region.
Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (U.S.), and Waters Corporation (U.S.) are some of the key players operating in the global life science instrumentation market.
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
